Screening compound: LXJUUFYZONFCRK-UHFFFAOYSA-N

Screening compound: LXJUUFYZONFCRK-UHFFFAOYSA-N
Screening compound: LXJUUFYZONFCRK-UHFFFAOYSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
LXJUUFYZONFCRK-UHFFFAOYSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G907-0371

Molecular Formula

C29H30ClN3O (C29 H30 ClN3 O)

Compound Name

N-benzyl-1-({1-[(3-chlorophenyl)methyl]-1H-indol-2-yl}methyl)piperidine-4-carboxamide

IUPAC name

N-benzyl-1-({1-[(3-chlorophenyl)methyl]-1H-indol-2-yl}methyl)piperidine-4-carboxamide

SMILES

O=C(C1CCN(Cc2cc(cccc3)c3n2Cc2cccc(Cl)c2)CC1)NCc1ccccc1

InChI

InChI=1S/C29H30ClN3O/c30-26-11-6-9-23(17-26)20-33-27(18-25-10-4-5-12-28(25)33)21-32-15-13-24(14-16-32)29(34)31-19-22-7-2-1-3-8-22/h1-12,17-18,24H,13-16,19-21H2,(H,31,34)

InChI Key

LXJUUFYZONFCRK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27167408

LXJUUFYZONFCRK-UHFFFAOYSA-N in Drug Discovery

Included in Screening Libraries

Anti-infective Library (19449 compounds)

Antiviral Library (67538 compounds)

CNS Targets (44014 compounds)

CORONAVIRUS Library (20774 compounds)

MCL1 Targeted Library (12200 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

PLpro Library (6343 compounds)

Protein-Protein Interaction Library (218420 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Immune system
  • animal
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
  • Antiviral
  • Infections
  • Immune system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Hemic and lymphatic
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with LXJUUFYZONFCRK-UHFFFAOYSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound LXJUUFYZONFCRK-UHFFFAOYSA-N?
Check Price and Availability of LXJUUFYZONFCRK-UHFFFAOYSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of LXJUUFYZONFCRK-UHFFFAOYSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for LXJUUFYZONFCRK-UHFFFAOYSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for LXJUUFYZONFCRK-UHFFFAOYSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of LXJUUFYZONFCRK-UHFFFAOYSA-N available by request